Uganda has launched the next phase of its mpox vaccination campaign with 100,000 additional doses. Targeting high-risk areas, the initiative focuses on young adults, especially as community transmission intensifies.

Mpox, previously known as monkeypox, spreads through close contact. Symptoms include fever, skin rash, and swollen lymph nodes.

The vaccination campaign is expanding to more vulnerable groups. Young adults aged 25 to 35 are prioritized in high-traffic districts in Kampala and beyond, aiming to reduce transmission rates effectively.

To combat mpox, Ugandan health officials are ramping up community awareness. Initiatives include radio talks and educational sessions to promote prevention through hygiene and safe practices, highlighting the importance of public cooperation.

The WHO has expressed critical concerns over Uganda's increasing mpox cases. They emphasize the importance of sustained public health measures to control the outbreak and protect the population.

Despite the vaccination push, stigma remains a challenge, especially among affected groups. Advocates call for equal access to vaccines and support for vulnerable communities to ensure comprehensive safety.

Looking ahead, Uganda's approach to mpox requires ongoing vaccination and awareness. The effectiveness of these strategies will depend on community cooperation and international support as the campaign evolves.